beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).

Department of Biomedical Sciences, Marquette University, 561 N. 15th Street, Rm 446 Milwaukee, WI 53233, USA.
Experimental Neurology (Impact Factor: 4.62). 05/2009; 217(2):429-33. DOI: 10.1016/j.expneurol.2009.04.002
Source: PubMed

ABSTRACT beta-N-methylamino-l-alanine (BMAA) is a non-protein amino acid implicated in the neurodegenerative disease amyotrophic lateral sclerosis/Parkinson-dementia complex (ALS/PDC) on Guam. BMAA has recently been discovered in the brains of Alzheimer's patients in Canada and is produced by various species of cyanobacteria around the world. These findings suggest the possibility that BMAA may be of concern not only for specific groups of Pacific Islanders, but for a much larger population. Previous studies have indicated that BMAA can act as an excitotoxin by acting on the NMDA receptor. We have shown that the mechanism of neurotoxicity is actually three-fold; it involves not only direct action on the NMDA receptor, but also activation of metabotropic glutamate receptor 5 (mGluR5) and induction of oxidative stress. We now explore the mechanism by which BMAA activates the mGluR5 receptor and induces oxidative stress. We found that BMAA inhibits the cystine/glutamate antiporter (system Xc(-)) mediated cystine uptake, which in turn leads to glutathione depletion and increased oxidative stress. BMAA also appears to drive glutamate release via system Xc(-) and this glutamate induces toxicity through activation of the mGluR5 receptor. Therefore, the oxidative stress and mGluR5 activation induced by BMAA are both mediated through action at system Xc(-). The multiple mechanisms of BMAA toxicity, particularly the depletion of glutathione and enhanced oxidative stress, may account for its ability to induce complex neurodegenerative diseases.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Response of selected biotransformation and antioxidant enzymes (glutathione S-transferase (GST), catalase (CAT), glutathione reductase (GR), and glutathione peroxidase (GPx)) of four different freshwater mussel species (Dreissena polymorpha, Corbicula javanicus, Anadonta cygnea, and Unio tumidus) was compared after a static exposure to 100 μg L−1 β-N-methylamino-L-alanine (BMAA) for 24 or 48 hours. Whereas D. polymorpha and A. cygnea did not show significant alteration in the activity of the selected enzymes, C. javanicus reacted with increased GST and GR activity after 24 hours and decreased CAT and GPx activity after 48 hours. U. tumidus displayed increased CAT and GR activity after 24 hours. Comparison between the concentration-dependent reaction of invasive D. polymorpha and native U. tumidus (exposure to 10, 100, and 500 μg L−1 BMAA) suggested a greater susceptibility of U. tumidus to BMAA. A further experiment on the time-dependent response to BMAA in U. tumidus gave an insight into the progression of the enzymatic response(s). An increase in CAT activity occurred after merely four hours, while a decrease of GPx activity was in turn only considerable after a longer exposure, for four or seven days. The data suggest that the BMAA exposure in freshwater mussels provokes changes in selected oxidative stress enzymes, which could result in the enhancement or inhibition of antioxidant systems.
    Toxicological and Environmental Chemistry 03/2014; 96(3). DOI:10.1080/02772248.2014.945452 · 0.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The environmental neurotoxins BMAA (β-N-methylamino-L-alanine) and BOAA (β-N-oxalylamino-L-alanine) are implicated as possible causative agents for the neurodegenerative diseases, amyotrophic lateral sclerosis/ Parkinsonism/Dementia complex (ALS/PDC) and neurolathyrism, respectively. Both are structural analogs of the neurotransmitter, glutamate, and bind postsynaptic glutamate receptors. In this study, the effect of ingestion of these toxins on the response of a singly-innervated, identified, glutamatergic postsynaptic cell in a living, undissected Drosophila is observed by intracellular recording. Previously we have reported that ingested BMAA behaves as an NMDA agonist that produces an abnormal NMDA response in the postsynaptic cell. It is shown here that BOAA also behaves as an NMDA agonist, and produces an effect very similar to that of BMAA on the postsynaptic response. In response to a single stimulus, the amplitude of the NMDA component is decreased, while the time to peak and duration of the NMDA component are greatly increased. No discernable effect on the AMPA component of the response was observed. Furthermore, both BMAA and BOAA cause an NMDAR-specific desensitization in response to repetitive stimulation at the physiological frequency for the postsynaptic cell (5Hz). The possibility that this phenomenon may represent a response to excessive Ca2 + entry through NMDAR channels is discussed. This desensitization phenomenon, as well as the abnormal NMDAR gating characteristics induced by BMAA, appears to be rescued during higher frequency stimulation (e.g. 10, 20 Hz).
    Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology 01/2014; DOI:10.1016/j.cbpc.2014.08.006 · 2.83 Impact Factor
  • Source


Available from
May 26, 2014